Simplera Sync Sensor; Guardian 4 Sensor
Medtronic MiniMed, Inc. · Decision date Dec 10, 2025
What did the FDA decide?
FDA records P250012/S005 as a supplement to PMA P250012, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 10, 2025.
FDA approval order statement
addition of an alternate manufacturing site for the final assembly of the Guardian 4 Sensor. The Guardian 4 sensor is a component of the MiniMed 780G System
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Clinical Chemistry
- Decision date
- Dec 10, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P250012/S005
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic MiniMed, Inc.
- Product code
- SFI
- Decision code
- OK30
- Decision date
- Dec 10, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Sensor, Glucose, Invasive, Component of automated insulin delivery system.
- Applicant
- Medtronic MiniMed, Inc.
- Product code
- SFI
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P250012. Subsequent supplements may change the device or its indications.
FDA decision timeline
P250012 · Original PMA
Simplera Sync Sensor, Guardian 4 Sensor
P250012/S001 · Related supplement
Simplera Sync Sensor, Guardian 4 Sensor
P250012/S003 · Related supplement
Simplera Sync Sensor, Guardian 4 Sensor
P250012/S002 · Related supplement
Guardian 4 Sensor
P250012/S004 · Related supplement
Simplera Sync Sensor, Guardian 4 Sensor
P250012/S005 received
Application receipt date recorded by FDA.
P250012/S006 · Related supplement
Simplera Sync Sensor
P250012/S007 · Related supplement
Simplera Sync Sensor
P250012/S005 · FDA decision
30-Day Notice
P250012/S009 · Related supplement
Simplera Sync Sensor
P250012/S010 · Related supplement
Simplera and Simplera Sync
P250012/S008 · Related supplement
Simplera Sync Sensor
P250012/S011 · Related supplement
Simplera Sync
Timeline entries are records held by MedtechLedger for P250012. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P250012
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic MiniMed, Inc. | PMA approval | Aug 6, 2025 | FDA | |
Simplera Sync Sensor, Guardian 4 SensorP250012/S001 | Medtronic MiniMed, Inc. | PMA supplement | Aug 25, 2025 | FDA |
Simplera Sync Sensor, Guardian 4 SensorP250012/S003 | Medtronic MiniMed, Inc. | PMA supplement | Sep 12, 2025 | FDA |
Guardian 4 SensorP250012/S002 | Medtronic MiniMed, Inc. | PMA supplement | Oct 9, 2025 | FDA |
Simplera Sync Sensor, Guardian 4 SensorP250012/S004 | Medtronic MiniMed, Inc. | PMA supplement | Oct 16, 2025 | FDA |
Simplera Sync SensorP250012/S006 | Medtronic MiniMed, Inc. | PMA supplement | Dec 5, 2025 | FDA |
Simplera Sync SensorP250012/S007 | Medtronic MiniMed, Inc. | PMA supplement | Dec 8, 2025 | FDA |
Simplera Sync SensorP250012/S009 | Medtronic MiniMed, Inc. | PMA supplement | Mar 19, 2026 | FDA |
Simplera and Simplera SyncP250012/S010 | Medtronic MiniMed, Inc. | PMA supplement | May 26, 2026 | FDA |
Simplera Sync SensorP250012/S008 | Medtronic MiniMed, Inc. | PMA supplement | Jun 12, 2026 | FDA |
Simplera SyncP250012/S011 | Medtronic MiniMed, Inc. | PMA supplement | Jul 21, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic MiniMed, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 18000 Devonshire St., Northridge, CA, 91325
Sources and methodology
- Original FDA record: P250012/S005
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





